Gyala Therapeutics Launches Innovative CAR-T Cell Therapy Trial Targeting Acute Leukemias Gyala Therapeutics has officially begun a Phase I/IIa clinical trial for GYA01, a CAR-T cell therapy for acute leukemias with limited treatment options.

Gyala Therapeutics Launches Innovative CAR-T Cell Therapy Trial Targeting Acute Leukemias #Spain #CAR-T_therapy #Gyala_Therapeutics #Acute_Leukemias #Valencia,_Barcelona